Topo Therapeutics
Cambridge, US · Founded 2024 · 3 known investors
Find your way into Topo Therapeutics
292 people in our graph share verified history with the Topo Therapeutics team — schools, employers, funds. One of them is your warm intro.
Steph Scottunlockedknows Hui Tian · together at Amgen (overlapped)
×10knows the team · via Amgen
knows the team · via University of Science and Technology of China
Topo Therapeutics is a drug discovery company developing treatments targeting ion channels and transmembrane proteins for conditions such as pain, epilepsy, and CNS, pulmonary, and renal diseases. It is built around scientific advisors and leadership with expertise in ion channel biology and biophysics.
Founders & leadership
MM
Madgalene MoranExecutive
MM
Magdalene MoranChief Executive Officer
Board
KK
BB
Bruce BeanBoard director
JJ
James Jeffrey Goater, Jr.Board director
Investors · 3
Reported raises · per SEC filings
Form D private placements$10.6M disclosed across 1 round · 2024
▶$10.6MraisedDec 2024 · 4 investors · BiotechnologyRule 506(b)
▶$10.6MraisedDec 2024 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bruce BeanDirector
- Hui TianExecutive Officer, Director
- Madgalene MoranExecutive Officer, Director
- Karin KleinhansDirector
- James Jeffrey Goater, Jr.Director
- Offering amount
- $95M
- Amount sold
- $10.6M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Topo Therapeutics went on to found or lead other companies.
In the news
Frequently asked questions
- What does Topo Therapeutics do?
- Topo Therapeutics is a drug discovery company developing treatments targeting ion channels and transmembrane proteins for conditions such as pain, epilepsy, and CNS, pulmonary, and renal diseases. It is built around scientific advisors and leadership with expertise in ion channel biology and biophysics.
- Who are Topo Therapeutics's investors?
- Topo Therapeutics's investors include SR One Capital Management, The Column Group, MRL Ventures Fund.
- How much funding has Topo Therapeutics raised?
- Topo Therapeutics has disclosed $10.6M raised across 1 round.
- Where is Topo Therapeutics headquartered?
- Topo Therapeutics is headquartered in Cambridge, US.